Literature DB >> 26122432

C-Terminal Threonine Reduces Aβ43 Amyloidogenicity Compared with Aβ42.

Saketh Chemuru1, Ravindra Kodali1, Ronald Wetzel2.   

Abstract

Aβ43, a product of the proteolysis of the amyloid precursor protein APP, is related to Aβ42 by an additional Thr residue at the C-terminus. Aβ43 is typically generated at low levels compared with the predominant Aβ42 and Aβ40 forms, but it has been suggested that this longer peptide might have an impact on amyloid-β aggregation and Alzheimer's disease that is out of proportion to its brain content. Here, we report that both Aβ42 and Aβ43 spontaneously aggregate into mature amyloid fibrils via sequential appearance of the same series of oligomeric and protofibrillar intermediates, the earliest of which appears to lack β-structure. In spite of the additional β-branched amino acid at the C-terminus, Aβ43 fibrils have fewer strong backbone H-bonds than Aβ42 fibrils, some of which are lost at the C-terminus. In contrast to previous reports, we found that Aβ43 spontaneously aggregates more slowly than Aβ42. In addition, Aβ43 fibrils are very inefficient at seeding Aβ42 amyloid formation, even though Aβ42 fibrils efficiently seed amyloid formation by Aβ43 monomers. Finally, mixtures of Aβ42 and Aβ43 aggregate more slowly than Aβ42 alone. Both in this Aβ42/Aβ43 co-aggregation reaction and in cross-seeding by Aβ42 fibrils, the structure of the Aβ43 in the product fibrils is influenced by the presence of Aβ42. The results provide new details of amyloid structure and assembly pathways, an example of structural plasticity in prion-like replication, and data showing that low levels of Aβ43 in the brain are unlikely to favorably impact the aggregation of Aβ42.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  amyloid; cross-seeding; hydrogen–deuterium exchange; polymorphism; weight-normalized ThT

Mesh:

Substances:

Year:  2015        PMID: 26122432      PMCID: PMC4691432          DOI: 10.1016/j.jmb.2015.06.008

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  93 in total

1.  Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research.

Authors:  Asad Jan; Dean M Hartley; Hilal A Lashuel
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

2.  Overcoming synthetic Abeta peptide aging: a new approach to an age-old problem.

Authors:  Claudia Manzoni; Laura Colombo; Massimo Messa; Alfredo Cagnotto; Laura Cantù; Elena Del Favero; Mario Salmona
Journal:  Amyloid       Date:  2009       Impact factor: 7.141

Review 3.  Polymorphism in the intermediates and products of amyloid assembly.

Authors:  Ravindra Kodali; Ronald Wetzel
Journal:  Curr Opin Struct Biol       Date:  2007-01-23       Impact factor: 6.809

4.  The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42.

Authors:  Verena H Finder; Ivana Vodopivec; Roger M Nitsch; Rudi Glockshuber
Journal:  J Mol Biol       Date:  2009-12-21       Impact factor: 5.469

Review 5.  Molecular mechanism of Thioflavin-T binding to amyloid fibrils.

Authors:  Matthew Biancalana; Shohei Koide
Journal:  Biochim Biophys Acta       Date:  2010-04-22

6.  Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated.

Authors:  Ravindra Kodali; Angela D Williams; Saketh Chemuru; Ronald Wetzel
Journal:  J Mol Biol       Date:  2010-06-18       Impact factor: 5.469

7.  A disulfide-linked amyloid-beta peptide dimer forms a protofibril-like oligomer through a distinct pathway from amyloid fibril formation.

Authors:  Takahiro Yamaguchi; Hisashi Yagi; Yuji Goto; Katsumi Matsuzaki; Masaru Hoshino
Journal:  Biochemistry       Date:  2010-08-24       Impact factor: 3.162

8.  Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils.

Authors:  Mahiuddin Ahmed; Judianne Davis; Darryl Aucoin; Takeshi Sato; Shivani Ahuja; Saburo Aimoto; James I Elliott; William E Van Nostrand; Steven O Smith
Journal:  Nat Struct Mol Biol       Date:  2010-04-11       Impact factor: 15.369

9.  Amide solvent protection analysis demonstrates that amyloid-beta(1-40) and amyloid-beta(1-42) form different fibrillar structures under identical conditions.

Authors:  Anders Olofsson; Malin Lindhagen-Persson; A Elisabeth Sauer-Eriksson; Anders Ohman
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

10.  Abeta40 protects non-toxic Abeta42 monomer from aggregation.

Authors:  Yilin Yan; Chunyu Wang
Journal:  J Mol Biol       Date:  2007-04-12       Impact factor: 5.469

View more
  11 in total

1.  Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions.

Authors:  Andrzej Stanisław Cieplak
Journal:  PLoS One       Date:  2017-09-18       Impact factor: 3.240

2.  Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.

Authors:  Kenneth W Drombosky; Sascha Rode; Ravi Kodali; Tija C Jacob; Michael J Palladino; Ronald Wetzel
Journal:  Neurobiol Dis       Date:  2018-08-30       Impact factor: 5.996

3.  Loss of Aβ43 Production Caused by Presenilin-1 Mutations in the Knockin Mouse Brain.

Authors:  Dan Xia; Raymond J Kelleher; Jie Shen
Journal:  Neuron       Date:  2016-04-20       Impact factor: 17.173

4.  Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice.

Authors:  Alejandro Ruiz-Riquelme; Alison Mao; Marim M Barghash; Heather H C Lau; Erica Stuart; Gabor G Kovacs; K Peter R Nilsson; Paul E Fraser; Gerold Schmitt-Ulms; Joel C Watts
Journal:  Acta Neuropathol Commun       Date:  2021-05-10       Impact factor: 7.801

5.  Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer.

Authors:  Bankanidhi Sahoo; Irene Arduini; Kenneth W Drombosky; Ravindra Kodali; Laurie H Sanders; J Timothy Greenamyre; Ronald Wetzel
Journal:  PLoS One       Date:  2016-06-06       Impact factor: 3.240

6.  Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.

Authors:  Ina S Almdahl; Camilla Lauridsen; Per Selnes; Lisa F Kalheim; Christopher Coello; Beata Gajdzik; Ina Møller; Marianne Wettergreen; Ramune Grambaite; Atle Bjørnerud; Geir Bråthen; Sigrid B Sando; Linda R White; Tormod Fladby
Journal:  Front Aging Neurosci       Date:  2017-02-07       Impact factor: 5.750

7.  Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer's Disease, But Has Similar Diagnostic Accuracy to Aβ42.

Authors:  Camilla Lauridsen; Sigrid B Sando; Ina Møller; Guro Berge; Precious K Pomary; Gøril R Grøntvedt; Øyvind Salvesen; Geir Bråthen; Linda R White
Journal:  Front Aging Neurosci       Date:  2017-06-28       Impact factor: 5.750

8.  Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer's disease diagnosis.

Authors:  Kazuma Murakami; Maki Tokuda; Takashi Suzuki; Yumi Irie; Mizuho Hanaki; Naotaka Izuo; Yoko Monobe; Ken-Ichi Akagi; Ryotaro Ishii; Harutsugu Tatebe; Takahiko Tokuda; Masahiro Maeda; Toshiaki Kume; Takahiko Shimizu; Kazuhiro Irie
Journal:  Sci Rep       Date:  2016-07-04       Impact factor: 4.379

9.  Rapid α-oligomer formation mediated by the Aβ C terminus initiates an amyloid assembly pathway.

Authors:  Pinaki Misra; Ravindra Kodali; Saketh Chemuru; Karunakar Kar; Ronald Wetzel
Journal:  Nat Commun       Date:  2016-08-22       Impact factor: 14.919

10.  Reduced Influence of apoE on Aβ43 Aggregation and Reduced Vascular Aβ43 Toxicity as Compared with Aβ40 and Aβ42.

Authors:  Lieke Jäkel; Elisanne A L M Biemans; Catharina J M Klijn; H Bea Kuiperij; Marcel M Verbeek
Journal:  Mol Neurobiol       Date:  2020-01-17       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.